1266238-63-4Relevant articles and documents
ESTER AND CARBONATE PYRIMIDINE COMPOUNDS AS JAK KINASE INHIBITORS
-
Page/Page column 40-41; 43, (2020/11/03)
The invention provides compounds of formula (I): (I) or pharmaceutically-acceptable salts thereof, that are inhibitors of Janus kinases and release an active metabolite in vivo. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat inflammatory skin diseases and other diseases.
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
-
Paragraph 0248; 0251-0252; 0264-0265, (2019/05/15)
The invention provides a compound of formula (I): or a pharmaceutically-acceptable salt thereof, that is an inhibitor of JAK kinases. The invention also provides pharmaceutical compositions comprising such compound, a crystalline form, methods of using such compound to treat inflammatory skin diseases and other diseases, and processes and intermediates useful for preparing such compound.
ARYL SUBSTITUTED PYRIMIDINES FOR USE IN INFLUENZA VIRUS INFECTION
-
Page/Page column 22, (2017/09/24)
The invention relates to compounds having the structure of formula (I) which can be used for the treatment of or against influenza infections.